Men overwhelmingly cite health-related reasons (58%), while women are far more likely to pursue GLP-1s for appearance-based goals (70%)
These symptoms frequently manifest during the initial treatment phase, affecting approximately 50% to 60% of patients [8], but they generally diminish over time, with their occurrence being dose-dependent
Full range of FDA-approved GLP-1s available on Hims & Hers
Right away, my new endocrinologist arranged comprehensive blood testingsomething no doctor had ever done despite past concerns about my weight
Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors, whereas semaglutide targets GLP-1 only and tirzepatide targets GLP-1 and GIP
In addition, HFD also promotes apoptotic processes at the hypothalamic level 62 , and weight-lowering therapies, as exercise, contribute to mitigate apoptosis in hypothalamic neurons 60